Sol-Gel Technologies Ltd. (SLGL) Insider Trading Activity

NASDAQ$66.16+2.35 (3.68%)
Market Cap
$208.91M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
44 of 849
Rank in Industry
32 of 491

SLGL Insider Trading Activity

SLGL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$11,220,180
42
100
Sells
$0
0
0

Related Transactions

Opaleye Management Inc.10 percent owner
42
$11.22M
0
$0
$11.22M

About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative, non-antibiotic topical cream designed for once-daily application, has successfully concluded Phase III trials for treating acne …

Insider Activity of Sol-Gel Technologies Ltd.

Over the last 12 months, insiders at Sol-Gel Technologies Ltd. have bought $11.22M and sold $0 worth of Sol-Gel Technologies Ltd. stock.

On average, over the past 5 years, insiders at Sol-Gel Technologies Ltd. have bought $11.22M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $11.22M.

The last purchase of 1,493 shares for transaction amount of $98,456 was made by Opaleye Management Inc. (10 percent owner) on 2026‑09‑11.

List of Insider Buy and Sell Transactions, Sol-Gel Technologies Ltd.

2026-09-11PurchaseOpaleye Management Inc.10 percent owner
1,493
0.0457%
$65.94
$98,456
+3.41%
2026-09-10PurchaseOpaleye Management Inc.10 percent owner
1,631
0.0499%
$66.80
$108,943
+2.09%
2026-09-09PurchaseOpaleye Management Inc.10 percent owner
3,097
0.0941%
$68.70
$212,779
-1.45%
2026-09-08PurchaseOpaleye Management Inc.10 percent owner
3,861
0.1171%
$68.82
$265,703
-1.71%
2026-09-04PurchaseOpaleye Management Inc.10 percent owner
3,018
0.0918%
$69.14
$208,677
-1.91%
2026-09-02PurchaseOpaleye Management Inc.10 percent owner
900
0.027%
$68.95
$62,054
-3.02%
2026-09-01PurchaseOpaleye Management Inc.10 percent owner
783
0.024%
$69.52
$54,434
-1.72%
2026-08-31PurchaseOpaleye Management Inc.10 percent owner
5,217
0.1576%
$68.27
$356,170
-1.09%
2026-08-28PurchaseOpaleye Management Inc.10 percent owner
35,113
1.0816%
$69.32
$2.43M
-0.44%
2026-08-12PurchaseOpaleye Management Inc.10 percent owner
951
0.0291%
$71.50
$67,997
-2.92%
2026-07-14PurchaseOpaleye Management Inc.10 percent owner
920
0.0319%
$73.43
$67,556
-4.80%
2026-07-13PurchaseOpaleye Management Inc.10 percent owner
775
0.0276%
$73.89
$57,263
-2.78%
2026-07-10PurchaseOpaleye Management Inc.10 percent owner
229
0.0079%
$73.95
$16,935
-2.71%
2026-07-08PurchaseOpaleye Management Inc.10 percent owner
300
0.0105%
$73.69
$22,107
-3.69%
2026-07-02PurchaseOpaleye Management Inc.10 percent owner
1,400
0.0498%
$71.97
$100,759
-2.28%
2026-07-01PurchaseOpaleye Management Inc.10 percent owner
312
0.0111%
$71.99
$22,461
+0.57%
2026-05-20PurchaseOpaleye Management Inc.10 percent owner
1,563
0.0549%
$64.43
$100,712
+12.57%
2026-05-13PurchaseOpaleye Management Inc.10 percent owner
1,937
0.0631%
$66.87
$129,527
+0.51%
2026-05-12PurchaseOpaleye Management Inc.10 percent owner
1,500
0.054%
$67.98
$101,975
+9.21%
2026-03-24PurchaseOpaleye Management Inc.10 percent owner
39,665
1.2813%
$72.00
$2.86M
-7.85%
Total: 42
*Gray background shows transactions not older than one year

SLGL Institutional Investors: Active Positions

Increased Positions8+88.89%280,974+50.31%
Decreased Positions2-22.22%122,765-21.98%
New Positions5New31,106New
Sold Out Positions<1Sold Out122,755Sold Out
Total Postitions15+66.67%716,711+28.33%

SLGL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.